Cancer Causes & Control

, Volume 24, Issue 4, pp 813–816

Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk

  • Elizabeth C. Lowcock
  • Michelle Cotterchio
  • Beatrice A. Boucher
Brief report

Abstract

Purpose

To investigate the association between intake of flaxseed—the richest source of dietary lignans (a class of phytoestrogens)—and breast cancer risk.

Methods

A food frequency questionnaire was used to measure the consumption of flaxseed and flax bread by 2,999 women with breast cancer and 3,370 healthy control women who participated in the Ontario Women’s Diet and Health Study (2002–2003). Logistic regression was used to investigate associations between consumption of flaxseed and flax bread and breast cancer risk. Confounding by established and suspected breast cancer risk factors, as well as dietary factors, was assessed.

Results

Flaxseed or flax bread was consumed at least weekly by 21 % of control women. None of the 19 variables assessed were identified as confounders of the associations between flaxseed or flax bread and breast cancer risk. Consumption of flaxseed was associated with a significant reduction in breast cancer risk (odds ratio (OR) = 0.82, 95 % confidence interval (CI) 0.69–0.97), as was consumption of flax bread (OR = 0.77, 95 % CI 0.67–0.89).

Conclusions

This Canadian study is, to our knowledge, the first to report on the association between flaxseed alone and breast cancer risk and has found that flaxseed intake is associated with a reduction in breast cancer risk. As dietary intake of flaxseed is modifiable, this finding may be of public health importance with respect to breast cancer prevention.

Keywords

Breast neoplasms Flax Lignans Phytoestrogens 

References

  1. 1.
    Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J (2010) Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92:141–153PubMedCrossRefGoogle Scholar
  2. 2.
    Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, Woodside JV (2009) Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies. Br J Cancer 100:1492–1498PubMedCrossRefGoogle Scholar
  3. 3.
    Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006) Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54:184–201PubMedCrossRefGoogle Scholar
  4. 4.
    Milder IE, Arts IC, van de Putte B, Venema DP, Hollman PC (2005) Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93:393–402PubMedCrossRefGoogle Scholar
  5. 5.
    Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH (2004) Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79:282–288PubMedGoogle Scholar
  6. 6.
    Fink BN, Steck SE, Wolff MS et al (2007) Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165:514–523PubMedCrossRefGoogle Scholar
  7. 7.
    Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F (2007) Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99:475–486PubMedCrossRefGoogle Scholar
  8. 8.
    Hedelin M, Löf M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E (2008) Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138:938–945PubMedGoogle Scholar
  9. 9.
    Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, Wolk A (2008) Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer 98:636–640PubMedCrossRefGoogle Scholar
  10. 10.
    McCann SE, Hootman KC, Weaver AM et al (2010) Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr 142:91–98Google Scholar
  11. 11.
    Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU (2008) Dietary phytoestrogen intake–lignans and isoflavones–and breast cancer risk (Canada). Cancer Causes Control 19:259–272PubMedCrossRefGoogle Scholar
  12. 12.
    Hedelin M, Klint A, Chang ET et al (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17:169–180PubMedCrossRefGoogle Scholar
  13. 13.
    Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17:1253–1261PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson LN, Cotterchio M, Vieth R, Knight JA (2010) Vitamin D and calcium intakes and breast cancer risk in pre- and post-menopausal women. Am J Clin Nutr 91:1699–1707PubMedCrossRefGoogle Scholar
  15. 15.
    Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G (2006) Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 9:84–93PubMedCrossRefGoogle Scholar
  16. 16.
    Flax Council of Canada. Flax nutrition profile. http://www.flaxcouncil.ca/english/index.jsp?p=g3&mp=nutrition. Accessed 8 Aug 2012
  17. 17.
    Maldonado G, Greenland S (1993) Simulation study of confounder selection strategies. Am J Epidemiol 138:923–936PubMedGoogle Scholar
  18. 18.
    Zaineddin AK, Buck K, Vrieling A et al (2012) The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case–control study. Nutr Cancer 64:652–665PubMedCrossRefGoogle Scholar
  19. 19.
    Hanna KL, O’Neill S, Lyons-Wall PM (2010) Intake of isoflavone and lignan phytoestrogens and associated demographic and lifestyle factors in older Australian women. Asia Pac J Clin Nutr 19:540–549PubMedGoogle Scholar
  20. 20.
    Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X (2009) Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90:288–297PubMedCrossRefGoogle Scholar
  21. 21.
    Pan A, Sun J, Chen Y et al (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2:e1148PubMedCrossRefGoogle Scholar
  22. 22.
    Pan A, Demark-Wahnefried W, Ye X et al (2009) Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr 101:1145–1149PubMedCrossRefGoogle Scholar
  23. 23.
    Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New YorkCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Elizabeth C. Lowcock
    • 1
  • Michelle Cotterchio
    • 1
    • 2
  • Beatrice A. Boucher
    • 1
    • 2
    • 3
  1. 1.Prevention and Cancer Control, Cancer Care OntarioTorontoCanada
  2. 2.Dalla Lana School of Public HealthUniversity of TorontoTorontoCanada
  3. 3.Department of Nutritional SciencesUniversity of TorontoTorontoCanada

Personalised recommendations